Humanetics

IN THE PRESS

Business

Humanetics Corporation Adds Two New Experts to its Board

October 26, 2021

·

3 min read

Drug Development

Humanetics Corporation Announces Results from Phase 1 Trial of BIO 300 Oral Powder

September 22, 2021

·

3 min read

FDA

Humanetics Corporation’s BIO 300 Receives Fast Track Designation from FDA

August 24, 2021

·

2 min read

BioMidwest

Humanetics Corporation Receives Funding From Regenerative Medicine Minnesota to Study New Drug for Triple Negative Breast Cancer

June 2, 2021

·

3 min read

Deals

Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19

January 26, 2021

·

3 min read

Business

ONL Therapeutics Names Connie Chang as Chief Operating OfficerCompany expands leadership team as it advances lead candidate ONL1204 beyond retinal detachment into the chronic conditions of glaucoma and dry age-related macular degeneration

January 19, 2021

·

3 min read

BioMidwest

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications

December 22, 2020

·

4 min read

Business

Amit Singhi joins Humanetics Group as Chief Financial Officer (CFO)

December 1, 2020

·

3 min read

BioMidwest

Humanetics Corporation Presents at the Annual Radiation Research Society Meeting

October 20, 2020

·

2 min read

Business

Former Surgeon General of the U.S. Navy, Vice Admiral Matthew L. Nathan, M.D., Joins Board of Directors at Minneapolis-based Humanetics

September 15, 2020

·

2 min read

JOBS